{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "../sources/OMNI_DIGITAL_SPA_19_CLI_LAB_INTEGRATED_spagnolo.pdf", "file_path": "../sources/OMNI_DIGITAL_SPA_19_CLI_LAB_INTEGRATED_spagnolo.pdf", "total_pages": 172, "format": "PDF 1.7", "title": "Presentazione standard di PowerPoint", "author": "Key-Stone", "subject": "", "keywords": "\"lang\": \"non-en\",\"country\": \"Spain\",\"year\": 2019", "creator": "Microsoft\u00ae PowerPoint\u00ae per Microsoft 365", "producer": "pikepdf 9.3.0", "creationDate": "D:20240927083340+02'00", "modDate": "D:20240927083340+02'00", "trapped": ""}, "page_content": " particular focus here is the donut chart detailing the responses from clinical settings. the donut chart is labeled \"clinicas,\" indicating data from clinic-based responses. it illustrates three key statistics using different shades and colors: 1. **39%** - represented in light blue/blue segment, signifying clinicians who use 3d imaging as a tool. 2. **36%** - shown in dark blue, referring to clinicians who occasionally use or do not use 3d imaging. 3. **12%** - indicated in navy blue/purple for clinicians who are not familiar with 3d imaging. 4. **1%** - the smallest segment, in dark gray, which represents clinicians who do not use 3d imaging and are unlikely to change their stance. the text surrounding the chart and accompanying images emphasize factors influencing the adoption of 3d imaging in medical practice, particularly in clinical and laboratory environments. the overall message is to highlight the varying degrees of familiarity, usage, and adoption rates of 3d imaging among clinicians.2015 uso de impresi\u00f3n 3d por parte de los proveedores de la cl\u00ednica \u00bfproporciona a sus pacientes dispositivos personalizados realizados con tecnolog", "type": "Document"}}